

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.31673721 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.31673721 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.08045174 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.08045174 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.59968387 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.30079797 |
| 7 | NADH metabolic process (GO:0006734) | 6.22552816 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.97869230 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.97869230 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.97869230 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.85320261 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.77904196 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.73600987 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.68578655 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.60206850 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.51986191 |
| 17 | sulfur amino acid catabolic process (GO:0000098) | 5.44147937 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.33404869 |
| 19 | urea metabolic process (GO:0019627) | 5.29420256 |
| 20 | urea cycle (GO:0000050) | 5.29420256 |
| 21 | cysteine metabolic process (GO:0006534) | 5.27244009 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.25476418 |
| 23 | protein carboxylation (GO:0018214) | 5.25476418 |
| 24 | angiotensin maturation (GO:0002003) | 5.10838931 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.09252956 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.01459060 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.00375086 |
| 28 | regulation of cholesterol esterification (GO:0010872) | 4.93817821 |
| 29 | fructose metabolic process (GO:0006000) | 4.93291829 |
| 30 | regulation of protein activation cascade (GO:2000257) | 4.92744694 |
| 31 | bile acid metabolic process (GO:0008206) | 4.90402985 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.88158070 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.86917823 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.81415359 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.78542959 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.76119453 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.76041182 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.76041182 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.76041182 |
| 40 | phospholipid efflux (GO:0033700) | 4.61446268 |
| 41 | regulation of complement activation (GO:0030449) | 4.60588029 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.56152958 |
| 43 | negative regulation of sterol transport (GO:0032372) | 4.53276369 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.53276369 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.50506360 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 4.50486804 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.49613978 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.49613978 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.47473134 |
| 50 | lysine metabolic process (GO:0006553) | 4.45863304 |
| 51 | lysine catabolic process (GO:0006554) | 4.45863304 |
| 52 | epoxygenase P450 pathway (GO:0019373) | 4.42557038 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.38650228 |
| 54 | homocysteine metabolic process (GO:0050667) | 4.37114249 |
| 55 | glycine metabolic process (GO:0006544) | 4.36707506 |
| 56 | ethanol oxidation (GO:0006069) | 4.30601591 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 4.30516772 |
| 58 | benzene-containing compound metabolic process (GO:0042537) | 4.26493159 |
| 59 | cellular glucuronidation (GO:0052695) | 4.25722991 |
| 60 | coenzyme catabolic process (GO:0009109) | 4.24141681 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.22115773 |
| 62 | * xenobiotic catabolic process (GO:0042178) | 4.21791111 |
| 63 | indolalkylamine metabolic process (GO:0006586) | 4.17424611 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 4.15144542 |
| 65 | amine catabolic process (GO:0009310) | 4.12587577 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 4.12587577 |
| 67 | cholesterol efflux (GO:0033344) | 4.11614862 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 4.11022653 |
| 69 | aldehyde catabolic process (GO:0046185) | 4.07770193 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 4.03792638 |
| 71 | response to nitrosative stress (GO:0051409) | 4.00822202 |
| 72 | serine family amino acid biosynthetic process (GO:0009070) | 4.00750957 |
| 73 | glutamate metabolic process (GO:0006536) | 3.96447451 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 3.94862797 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.92559783 |
| 76 | ketone body metabolic process (GO:1902224) | 3.88621974 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.84616696 |
| 78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.84616696 |
| 79 | arginine metabolic process (GO:0006525) | 3.81603897 |
| 80 | drug catabolic process (GO:0042737) | 3.80376288 |
| 81 | fibrinolysis (GO:0042730) | 3.79645527 |
| 82 | glucuronate metabolic process (GO:0019585) | 3.79563559 |
| 83 | uronic acid metabolic process (GO:0006063) | 3.79563559 |
| 84 | cofactor catabolic process (GO:0051187) | 3.79402999 |
| 85 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.78039314 |
| 86 | short-chain fatty acid metabolic process (GO:0046459) | 3.73470915 |
| 87 | glycosphingolipid catabolic process (GO:0046479) | 3.72369751 |
| 88 | organic acid catabolic process (GO:0016054) | 3.71880394 |
| 89 | carboxylic acid catabolic process (GO:0046395) | 3.71880394 |
| 90 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.71281201 |
| 91 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70224388 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70192048 |
| 93 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68671572 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.67938095 |
| 95 | cholesterol homeostasis (GO:0042632) | 3.64572842 |
| 96 | negative regulation of lipase activity (GO:0060192) | 3.63177163 |
| 97 | plasma lipoprotein particle organization (GO:0071827) | 3.62891952 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.61605201 |
| 99 | acetyl-CoA metabolic process (GO:0006084) | 3.61377506 |
| 100 | sterol homeostasis (GO:0055092) | 3.58242134 |
| 101 | flavonoid metabolic process (GO:0009812) | 3.57264065 |
| 102 | regulation of cholesterol homeostasis (GO:2000188) | 3.55062365 |
| 103 | complement activation, classical pathway (GO:0006958) | 3.54325516 |
| 104 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53493078 |
| 105 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.53493078 |
| 106 | NAD biosynthetic process (GO:0009435) | 3.52971984 |
| 107 | protein-lipid complex assembly (GO:0065005) | 3.52302078 |
| 108 | monocarboxylic acid catabolic process (GO:0072329) | 3.52178531 |
| 109 | glycolipid catabolic process (GO:0019377) | 3.51889796 |
| 110 | peptide catabolic process (GO:0043171) | 3.47931425 |
| 111 | neutrophil activation involved in immune response (GO:0002283) | 3.23829782 |
| 112 | drug metabolic process (GO:0017144) | 3.23278863 |
| 113 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.15388850 |
| 114 | tricarboxylic acid cycle (GO:0006099) | 3.11460687 |
| 115 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.09130651 |
| 116 | oxaloacetate metabolic process (GO:0006107) | 3.03777781 |
| 117 | intestinal absorption (GO:0050892) | 3.02809132 |
| 118 | diacylglycerol metabolic process (GO:0046339) | 3.02461842 |
| 119 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.01764687 |
| 120 | regulation of skeletal muscle contraction (GO:0014819) | 3.01348054 |
| 121 | regulation of guanylate cyclase activity (GO:0031282) | 3.00274531 |
| 122 | cyclooxygenase pathway (GO:0019371) | 2.96654598 |
| 123 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.92714056 |
| 124 | glycoside metabolic process (GO:0016137) | 2.92611623 |
| 125 | * glutathione metabolic process (GO:0006749) | 2.92136636 |
| 126 | gluconeogenesis (GO:0006094) | 2.91575556 |
| 127 | creatine metabolic process (GO:0006600) | 2.89207503 |
| 128 | * glutathione derivative metabolic process (GO:1901685) | 2.87659658 |
| 129 | * glutathione derivative biosynthetic process (GO:1901687) | 2.87659658 |
| 130 | lipoprotein transport (GO:0042953) | 2.86985055 |
| 131 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85931795 |
| 132 | ceramide catabolic process (GO:0046514) | 2.84022348 |
| 133 | fatty acid beta-oxidation (GO:0006635) | 2.82742714 |
| 134 | actin-myosin filament sliding (GO:0033275) | 2.80947978 |
| 135 | muscle filament sliding (GO:0030049) | 2.80947978 |
| 136 | very long-chain fatty acid metabolic process (GO:0000038) | 2.74996847 |
| 137 | adhesion of symbiont to host cell (GO:0044650) | 2.73946655 |
| 138 | virion attachment to host cell (GO:0019062) | 2.73946655 |
| 139 | fatty acid catabolic process (GO:0009062) | 2.73537453 |
| 140 | cGMP-mediated signaling (GO:0019934) | 2.72501413 |
| 141 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.70433220 |
| 142 | tricarboxylic acid metabolic process (GO:0072350) | 2.70040325 |
| 143 | hexose biosynthetic process (GO:0019319) | 2.67249519 |
| 144 | regulation of lipoprotein metabolic process (GO:0050746) | 2.63986060 |
| 145 | regulation of cellular extravasation (GO:0002691) | 2.61820045 |
| 146 | monosaccharide biosynthetic process (GO:0046364) | 2.60735476 |
| 147 | glycosylceramide metabolic process (GO:0006677) | 2.58625793 |
| 148 | pinocytosis (GO:0006907) | 2.58601251 |
| 149 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.56229803 |
| 150 | arachidonic acid metabolic process (GO:0019369) | 2.55867212 |
| 151 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.55366398 |
| 152 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.55366398 |
| 153 | endocrine process (GO:0050886) | 2.55366398 |
| 154 | L-ascorbic acid metabolic process (GO:0019852) | 2.54503867 |
| 155 | regulation of cholesterol metabolic process (GO:0090181) | 2.54121905 |
| 156 | adhesion of symbiont to host (GO:0044406) | 2.53366949 |
| 157 | glucan catabolic process (GO:0009251) | 2.52966729 |
| 158 | galactose catabolic process (GO:0019388) | 2.52917526 |
| 159 | fatty acid oxidation (GO:0019395) | 2.51231446 |
| 160 | arginine catabolic process (GO:0006527) | 2.49340759 |
| 161 | lipid oxidation (GO:0034440) | 2.49240307 |
| 162 | response to thyroid hormone (GO:0097066) | 2.48235303 |
| 163 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.47156181 |
| 164 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.46687048 |
| 165 | protein-lipid complex subunit organization (GO:0071825) | 2.45909877 |
| 166 | quinone biosynthetic process (GO:1901663) | 2.45740136 |
| 167 | glutathione biosynthetic process (GO:0006750) | 2.44664577 |
| 168 | carnitine metabolic process (GO:0009437) | 2.44596952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.11537054 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.01801405 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.78282518 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.16569074 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.42722642 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.18949156 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.95541284 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06933041 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.67853005 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24342853 |
| 11 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.09325578 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00127296 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6123015 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.99570868 |
| 15 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.92496556 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76213558 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67779536 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58912077 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55443743 |
| 20 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45292018 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41897448 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38623394 |
| 23 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.36822606 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35028203 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33642828 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33596854 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33434912 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32667390 |
| 29 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31475863 |
| 30 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28711613 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.28033865 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27309033 |
| 33 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25017059 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24353199 |
| 35 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22752200 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22674671 |
| 37 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21697130 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.21453397 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20915726 |
| 40 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18235139 |
| 41 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15647836 |
| 42 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15046638 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14901304 |
| 44 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.14784808 |
| 45 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.14600401 |
| 46 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12149176 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11918073 |
| 48 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10485513 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09565711 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09450126 |
| 51 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08909634 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07109357 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07033186 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06243118 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05206945 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03619667 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.03505552 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.03250070 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02837544 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01936330 |
| 61 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01299658 |
| 62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97508721 |
| 63 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.96736778 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.96366457 |
| 65 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95971888 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95786844 |
| 67 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94789322 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94732198 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94119057 |
| 70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93706733 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93594059 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93119499 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92972578 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88123353 |
| 75 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86408157 |
| 76 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84176003 |
| 77 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.83476044 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.83191049 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80803526 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80074667 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79452667 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79175900 |
| 83 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78329601 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77818632 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.77771132 |
| 86 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75160467 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73882541 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72320399 |
| 89 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.72053390 |
| 90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71865387 |
| 91 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.70209574 |
| 92 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70035973 |
| 93 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67094855 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66301853 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62790870 |
| 96 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.61239720 |
| 97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.60025878 |
| 98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.59515955 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59142290 |
| 100 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58531050 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.57916797 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57027877 |
| 103 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.55824571 |
| 104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54962893 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.54509221 |
| 106 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.53411727 |
| 107 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53290292 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.52894562 |
| 109 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.50930203 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.50204371 |
| 111 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50188598 |
| 112 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.49439400 |
| 113 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.49439400 |
| 114 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49196399 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.49175873 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.49107933 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48979795 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.48816430 |
| 119 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48791876 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.48589035 |
| 121 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.48498992 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48143873 |
| 123 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47942744 |
| 124 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47804479 |
| 125 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.46322956 |
| 126 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45765183 |
| 127 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.45741763 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45667087 |
| 129 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45349092 |
| 130 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.45036790 |
| 131 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.44944125 |
| 132 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44243951 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44022481 |
| 134 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.43993002 |
| 135 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.43823719 |
| 136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43802913 |
| 137 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.43622424 |
| 138 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.43515968 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.43396893 |
| 140 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42710392 |
| 141 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41960856 |
| 142 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.40811676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.28579400 |
| 2 | MP0005360_urolithiasis | 7.19630538 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.15279025 |
| 4 | MP0005365_abnormal_bile_salt | 6.10417551 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.05285034 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.54314831 |
| 7 | MP0003252_abnormal_bile_duct | 3.66223916 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.53148408 |
| 9 | MP0009840_abnormal_foam_cell | 3.52978734 |
| 10 | MP0005083_abnormal_biliary_tract | 2.95561691 |
| 11 | MP0003195_calcinosis | 2.74047441 |
| 12 | MP0005332_abnormal_amino_acid | 2.68208876 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59877040 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.41276398 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.34510434 |
| 16 | MP0000609_abnormal_liver_physiology | 2.14439456 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09977681 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.02811873 |
| 19 | MP0004147_increased_porphyrin_level | 2.01825895 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.92190324 |
| 21 | MP0010155_abnormal_intestine_physiology | 1.78922035 |
| 22 | MP0001764_abnormal_homeostasis | 1.74259389 |
| 23 | MP0003646_muscle_fatigue | 1.73574420 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.69170472 |
| 25 | MP0003868_abnormal_feces_composition | 1.68970303 |
| 26 | MP0008004_abnormal_stomach_pH | 1.65918427 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65819773 |
| 28 | MP0009697_abnormal_copulation | 1.61101553 |
| 29 | MP0000749_muscle_degeneration | 1.58286117 |
| 30 | MP0003186_abnormal_redox_activity | 1.54574738 |
| 31 | MP0008260_abnormal_autophagy | 1.54259584 |
| 32 | MP0004036_abnormal_muscle_relaxation | 1.51505760 |
| 33 | MP0000751_myopathy | 1.50937223 |
| 34 | MP0003879_abnormal_hair_cell | 1.49561763 |
| 35 | MP0005330_cardiomyopathy | 1.43227910 |
| 36 | MP0000343_altered_response_to | 1.42515664 |
| 37 | MP0005451_abnormal_body_composition | 1.39577720 |
| 38 | MP0004084_abnormal_cardiac_muscle | 1.35600980 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.33058375 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.30431575 |
| 41 | MP0004510_myositis | 1.30370638 |
| 42 | MP0003011_delayed_dark_adaptation | 1.29185105 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.25571573 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.22394263 |
| 45 | MP0005165_increased_susceptibility_to | 1.22090721 |
| 46 | MP0000598_abnormal_liver_morphology | 1.19994253 |
| 47 | MP0008775_abnormal_heart_ventricle | 1.18564737 |
| 48 | MP0005671_abnormal_response_to | 1.18267980 |
| 49 | MP0000372_irregular_coat_pigmentation | 1.11662575 |
| 50 | MP0004215_abnormal_myocardial_fiber | 1.11511015 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.11017397 |
| 52 | MP0009764_decreased_sensitivity_to | 1.09725835 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.09378633 |
| 54 | MP0003866_abnormal_defecation | 1.08647170 |
| 55 | MP0001664_abnormal_digestion | 1.07064081 |
| 56 | MP0009763_increased_sensitivity_to | 1.06136432 |
| 57 | MP0008469_abnormal_protein_level | 1.04748101 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.02896909 |
| 59 | MP0002972_abnormal_cardiac_muscle | 1.02344847 |
| 60 | MP0000604_amyloidosis | 1.02245411 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.01728449 |
| 62 | MP0000747_muscle_weakness | 1.01276230 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.00889282 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.00349689 |
| 65 | MP0005647_abnormal_sex_gland | 1.00166436 |
| 66 | MP0000013_abnormal_adipose_tissue | 0.97628371 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 0.96982980 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 0.96586124 |
| 69 | MP0005387_immune_system_phenotype | 0.96581937 |
| 70 | MP0001790_abnormal_immune_system | 0.96581937 |
| 71 | MP0001533_abnormal_skeleton_physiology | 0.93131409 |
| 72 | MP0009642_abnormal_blood_homeostasis | 0.91662405 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.90419217 |
| 74 | MP0010368_abnormal_lymphatic_system | 0.88364862 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 0.87499664 |
| 76 | MP0005000_abnormal_immune_tolerance | 0.86194627 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.85097651 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 0.82865560 |
| 79 | MP0005620_abnormal_muscle_contractility | 0.81987482 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 0.81667153 |
| 81 | MP0003436_decreased_susceptibility_to | 0.81111042 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.79776021 |
| 83 | MP0005408_hypopigmentation | 0.78112936 |
| 84 | MP0002254_reproductive_system_inflammat | 0.77646253 |
| 85 | MP0006138_congestive_heart_failure | 0.77104633 |
| 86 | MP0001800_abnormal_humoral_immune | 0.77019572 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.76234994 |
| 88 | MP0004130_abnormal_muscle_cell | 0.73702952 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.73552364 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 0.73115667 |
| 91 | MP0005266_abnormal_metabolism | 0.73049423 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 0.71480212 |
| 93 | MP0003724_increased_susceptibility_to | 0.69697479 |
| 94 | MP0005334_abnormal_fat_pad | 0.69666109 |
| 95 | MP0001756_abnormal_urination | 0.67434940 |
| 96 | MP0002971_abnormal_brown_adipose | 0.67139674 |
| 97 | MP0005535_abnormal_body_temperature | 0.66596473 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.65353068 |
| 99 | MP0005670_abnormal_white_adipose | 0.63936143 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.62032171 |
| 101 | MP0001661_extended_life_span | 0.61343547 |
| 102 | MP0003690_abnormal_glial_cell | 0.59896453 |
| 103 | MP0006082_CNS_inflammation | 0.57052334 |
| 104 | MP0009053_abnormal_anal_canal | 0.55979475 |
| 105 | MP0005448_abnormal_energy_balance | 0.55522594 |
| 106 | MP0003329_amyloid_beta_deposits | 0.55234323 |
| 107 | MP0003075_altered_response_to | 0.53842733 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.53203103 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.51533007 |
| 110 | MP0000639_abnormal_adrenal_gland | 0.51071615 |
| 111 | MP0009785_altered_susceptibility_to | 0.50525063 |
| 112 | MP0005166_decreased_susceptibility_to | 0.50069337 |
| 113 | MP0008873_increased_physiological_sensi | 0.49558336 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.48900272 |
| 115 | MP0002928_abnormal_bile_duct | 0.48203280 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.47178859 |
| 117 | MP0001853_heart_inflammation | 0.44872882 |
| 118 | MP0008874_decreased_physiological_sensi | 0.43498410 |
| 119 | MP0000249_abnormal_blood_vessel | 0.41707635 |
| 120 | MP0003953_abnormal_hormone_level | 0.40447003 |
| 121 | MP0002419_abnormal_innate_immunity | 0.38219698 |
| 122 | MP0005395_other_phenotype | 0.37840626 |
| 123 | MP0005025_abnormal_response_to | 0.37333568 |
| 124 | MP0009115_abnormal_fat_cell | 0.37299759 |
| 125 | MP0002970_abnormal_white_adipose | 0.35522745 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.35176500 |
| 127 | MP0002132_abnormal_respiratory_system | 0.35172434 |
| 128 | MP0005666_abnormal_adipose_tissue | 0.34893525 |
| 129 | MP0003718_maternal_effect | 0.34653990 |
| 130 | MP0004883_abnormal_blood_vessel | 0.32120971 |
| 131 | MP0008872_abnormal_physiological_respon | 0.32021749 |
| 132 | MP0004381_abnormal_hair_follicle | 0.31675227 |
| 133 | MP0005164_abnormal_response_to | 0.30868648 |
| 134 | MP0002796_impaired_skin_barrier | 0.30850739 |
| 135 | MP0000685_abnormal_immune_system | 0.30064307 |
| 136 | MP0009672_abnormal_birth_weight | 0.28408358 |
| 137 | MP0001243_abnormal_dermal_layer | 0.28256142 |
| 138 | MP0002135_abnormal_kidney_morphology | 0.26855972 |
| 139 | MP0001881_abnormal_mammary_gland | 0.26585027 |
| 140 | MP0004947_skin_inflammation | 0.26126299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.30861269 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.97844968 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.91801578 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.41033022 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.28971719 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.21230459 |
| 7 | Xanthomatosis (HP:0000991) | 6.00913538 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.37257136 |
| 9 | Complement deficiency (HP:0004431) | 4.92443064 |
| 10 | Joint hemorrhage (HP:0005261) | 4.61507013 |
| 11 | Hyperammonemia (HP:0001987) | 4.61447861 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.56876686 |
| 13 | Hyperglycinemia (HP:0002154) | 4.32449398 |
| 14 | Ketosis (HP:0001946) | 4.28537898 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.24962009 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19541886 |
| 17 | Epidermoid cyst (HP:0200040) | 4.14178196 |
| 18 | Hyperglycinuria (HP:0003108) | 4.08533181 |
| 19 | Petechiae (HP:0000967) | 4.07395332 |
| 20 | Hypoglycemic coma (HP:0001325) | 4.07371973 |
| 21 | Fat malabsorption (HP:0002630) | 4.01107747 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.99632052 |
| 23 | Rhabdomyolysis (HP:0003201) | 3.98121463 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.96928180 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.96928180 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.94016829 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.89421811 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.89010639 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.83565536 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74208751 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.70497221 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67121462 |
| 33 | Abnormality of complement system (HP:0005339) | 3.67101624 |
| 34 | Nemaline bodies (HP:0003798) | 3.62081252 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61537442 |
| 36 | Myoglobinuria (HP:0002913) | 3.57371338 |
| 37 | Purpura (HP:0000979) | 3.54990874 |
| 38 | Muscle fiber inclusion bodies (HP:0100299) | 3.54131714 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.54044562 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.53999624 |
| 41 | Exercise-induced myalgia (HP:0003738) | 3.53842549 |
| 42 | Hyperbilirubinemia (HP:0002904) | 3.45601677 |
| 43 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.42493042 |
| 44 | Ketoacidosis (HP:0001993) | 3.22730776 |
| 45 | Steatorrhea (HP:0002570) | 3.09582235 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.09052244 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 3.02049086 |
| 48 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01297194 |
| 49 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.92474340 |
| 50 | Exercise-induced muscle cramps (HP:0003710) | 2.90918776 |
| 51 | Myocardial infarction (HP:0001658) | 2.87182287 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.86074773 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.86074773 |
| 54 | Metabolic acidosis (HP:0001942) | 2.85183374 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78889928 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.77411516 |
| 57 | Myopathic facies (HP:0002058) | 2.71852912 |
| 58 | Spontaneous abortion (HP:0005268) | 2.70376520 |
| 59 | Lethargy (HP:0001254) | 2.70008123 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.68680515 |
| 61 | Abnormality of purine metabolism (HP:0004352) | 2.66697180 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.63849580 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.63753924 |
| 64 | Hypochromic microcytic anemia (HP:0004840) | 2.62807388 |
| 65 | Skin nodule (HP:0200036) | 2.53768401 |
| 66 | Amyloidosis (HP:0011034) | 2.53292064 |
| 67 | Ileus (HP:0002595) | 2.52168250 |
| 68 | Vascular calcification (HP:0004934) | 2.50182476 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.49763553 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.49763553 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.49763553 |
| 72 | Cerebral edema (HP:0002181) | 2.49356575 |
| 73 | Distal lower limb muscle weakness (HP:0009053) | 2.46585816 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.41023395 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.40779685 |
| 76 | Cerebral palsy (HP:0100021) | 2.40107569 |
| 77 | Hepatic necrosis (HP:0002605) | 2.38716321 |
| 78 | Asymmetric septal hypertrophy (HP:0001670) | 2.38393214 |
| 79 | Malnutrition (HP:0004395) | 2.37407652 |
| 80 | Late onset (HP:0003584) | 2.36347660 |
| 81 | Spastic diplegia (HP:0001264) | 2.35626054 |
| 82 | Cholelithiasis (HP:0001081) | 2.35178962 |
| 83 | Pancreatitis (HP:0001733) | 2.34436847 |
| 84 | Acanthocytosis (HP:0001927) | 2.34360394 |
| 85 | Irritability (HP:0000737) | 2.33926319 |
| 86 | Neonatal onset (HP:0003623) | 2.31428525 |
| 87 | Cholecystitis (HP:0001082) | 2.31108921 |
| 88 | Abnormal gallbladder physiology (HP:0012438) | 2.31108921 |
| 89 | Gout (HP:0001997) | 2.27930021 |
| 90 | Opisthotonus (HP:0002179) | 2.23587609 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 2.23148227 |
| 92 | Epistaxis (HP:0000421) | 2.22562063 |
| 93 | Mitral stenosis (HP:0001718) | 2.22086581 |
| 94 | Vomiting (HP:0002013) | 2.21384964 |
| 95 | Prolonged neonatal jaundice (HP:0006579) | 2.20476030 |
| 96 | White forelock (HP:0002211) | 2.20342281 |
| 97 | Cardiovascular calcification (HP:0011915) | 2.20142422 |
| 98 | Glomerulonephritis (HP:0000099) | 2.18527838 |
| 99 | Gingival bleeding (HP:0000225) | 2.18414440 |
| 100 | Menorrhagia (HP:0000132) | 2.16454335 |
| 101 | Thrombophlebitis (HP:0004418) | 2.13477289 |
| 102 | Patchy hypopigmentation of hair (HP:0011365) | 2.12020925 |
| 103 | Dysostosis multiplex (HP:0000943) | 2.11362984 |
| 104 | Sensorimotor neuropathy (HP:0007141) | 2.11168103 |
| 105 | EMG: myopathic abnormalities (HP:0003458) | 2.10260630 |
| 106 | Type 1 muscle fiber predominance (HP:0003803) | 2.09527036 |
| 107 | Bulbar palsy (HP:0001283) | 2.09488468 |
| 108 | Esophageal varix (HP:0002040) | 2.09241173 |
| 109 | Proximal tubulopathy (HP:0000114) | 2.08745804 |
| 110 | Brushfield spots (HP:0001088) | 2.08730229 |
| 111 | Pigmentary retinal degeneration (HP:0001146) | 2.05565736 |
| 112 | Bundle branch block (HP:0011710) | 2.04212696 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03624952 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 2.03439786 |
| 115 | Hepatocellular necrosis (HP:0001404) | 2.01745687 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 2.01500024 |
| 117 | Muscle stiffness (HP:0003552) | 2.01479099 |
| 118 | Abnormal pupillary function (HP:0007686) | 2.00958923 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 1.97510639 |
| 120 | Hyporeflexia of lower limbs (HP:0002600) | 1.96675440 |
| 121 | Neck muscle weakness (HP:0000467) | 1.96128838 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95999451 |
| 123 | Abnormality of the gallbladder (HP:0005264) | 1.95691599 |
| 124 | Sudden death (HP:0001699) | 1.94980996 |
| 125 | Increased mean platelet volume (HP:0011877) | 1.93838129 |
| 126 | Nausea (HP:0002018) | 1.93441552 |
| 127 | Acute encephalopathy (HP:0006846) | 1.93077350 |
| 128 | Abnormality of glycolysis (HP:0004366) | 1.91993825 |
| 129 | Abnormality of macrophages (HP:0004311) | 1.91742111 |
| 130 | Chronic diarrhea (HP:0002028) | 1.91317193 |
| 131 | Hemorrhage of the eye (HP:0011885) | 1.91154225 |
| 132 | Elevated hepatic transaminases (HP:0002910) | 1.90973047 |
| 133 | Renal cortical cysts (HP:0000803) | 1.89732644 |
| 134 | Axonal loss (HP:0003447) | 1.89081460 |
| 135 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.88737970 |
| 136 | Increased serum pyruvate (HP:0003542) | 1.87620873 |
| 137 | Congenital sensorineural hearing impairment (HP:0008527) | 1.87002712 |
| 138 | Enlarged kidneys (HP:0000105) | 1.86551926 |
| 139 | Hepatosplenomegaly (HP:0001433) | 1.85998940 |
| 140 | Poikilocytosis (HP:0004447) | 1.85975336 |
| 141 | Paralysis (HP:0003470) | 1.85870781 |
| 142 | Eczematoid dermatitis (HP:0000976) | 1.85291618 |
| 143 | Hypophosphatemia (HP:0002148) | 1.84957310 |
| 144 | Hydroxyprolinuria (HP:0003080) | 1.84543250 |
| 145 | Abnormality of proline metabolism (HP:0010907) | 1.84543250 |
| 146 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.84158289 |
| 147 | Abnormal platelet volume (HP:0011876) | 1.83597343 |
| 148 | Rickets (HP:0002748) | 1.83150660 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81731257 |
| 150 | Glycosuria (HP:0003076) | 1.81464067 |
| 151 | Abnormality of urine glucose concentration (HP:0011016) | 1.81464067 |
| 152 | Increased muscle lipid content (HP:0009058) | 1.79657090 |
| 153 | Tongue fasciculations (HP:0001308) | 1.79650578 |
| 154 | Dilated cardiomyopathy (HP:0001644) | 1.79146942 |
| 155 | Hypertriglyceridemia (HP:0002155) | 1.76603814 |
| 156 | Nephritis (HP:0000123) | 1.76368827 |
| 157 | Increased cerebral lipofuscin (HP:0011813) | 1.75854401 |
| 158 | Pulmonary embolism (HP:0002204) | 1.75462342 |
| 159 | Symptomatic seizures (HP:0011145) | 1.75406485 |
| 160 | Increased serum ferritin (HP:0003281) | 1.75379264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.44535209 |
| 2 | ERN1 | 5.01678668 |
| 3 | PDK2 | 4.19923245 |
| 4 | SIK1 | 3.83541402 |
| 5 | FGFR4 | 3.82028656 |
| 6 | OBSCN | 3.25969069 |
| 7 | FLT3 | 2.79828902 |
| 8 | MST4 | 2.75321375 |
| 9 | TAOK3 | 2.73787313 |
| 10 | PKN2 | 2.71348915 |
| 11 | RIPK4 | 2.65984219 |
| 12 | PIK3CG | 2.44447409 |
| 13 | MAPKAPK3 | 2.28197457 |
| 14 | INSRR | 2.27216620 |
| 15 | TRIB3 | 2.16604660 |
| 16 | PHKG2 | 2.08339613 |
| 17 | PHKG1 | 2.08339613 |
| 18 | TESK1 | 1.98689042 |
| 19 | TYK2 | 1.92466771 |
| 20 | MAP2K4 | 1.86896500 |
| 21 | MUSK | 1.84901728 |
| 22 | PRPF4B | 1.83547047 |
| 23 | ERBB4 | 1.79319549 |
| 24 | MAP2K3 | 1.74196989 |
| 25 | FRK | 1.67171282 |
| 26 | IRAK3 | 1.66925461 |
| 27 | MST1R | 1.61860693 |
| 28 | ABL2 | 1.57129238 |
| 29 | MAPK11 | 1.55360937 |
| 30 | KDR | 1.53944382 |
| 31 | NEK9 | 1.46807645 |
| 32 | MAP3K14 | 1.44878400 |
| 33 | TBK1 | 1.42490920 |
| 34 | LMTK2 | 1.37193323 |
| 35 | TTN | 1.27804415 |
| 36 | MARK3 | 1.24052519 |
| 37 | PTK6 | 1.22130623 |
| 38 | DAPK3 | 1.20260819 |
| 39 | MATK | 1.17859232 |
| 40 | JAK2 | 1.17733818 |
| 41 | MAP3K3 | 1.14413530 |
| 42 | GRK6 | 1.13685549 |
| 43 | BMPR2 | 1.11434324 |
| 44 | LIMK1 | 1.10767830 |
| 45 | TGFBR2 | 1.07259156 |
| 46 | MAP3K12 | 1.06185921 |
| 47 | CDK19 | 1.05001265 |
| 48 | VRK2 | 1.04712233 |
| 49 | MAP3K11 | 1.04431277 |
| 50 | DAPK2 | 1.03718539 |
| 51 | MAPK15 | 1.02811899 |
| 52 | TIE1 | 1.02030799 |
| 53 | BMX | 1.01865241 |
| 54 | MAPK4 | 1.01159796 |
| 55 | CCNB1 | 1.00771115 |
| 56 | DDR2 | 1.00140262 |
| 57 | ZAP70 | 0.99738912 |
| 58 | MAP3K7 | 0.99700684 |
| 59 | MYLK | 0.97530541 |
| 60 | MAP2K6 | 0.95554136 |
| 61 | MAP3K10 | 0.95163743 |
| 62 | FGR | 0.92405964 |
| 63 | PINK1 | 0.91484400 |
| 64 | ILK | 0.90021886 |
| 65 | CAMK2D | 0.89596619 |
| 66 | JAK1 | 0.87739191 |
| 67 | PRKAA2 | 0.86879631 |
| 68 | EIF2AK1 | 0.85348040 |
| 69 | EPHA3 | 0.84785086 |
| 70 | RIPK1 | 0.83891546 |
| 71 | PBK | 0.83138549 |
| 72 | ARAF | 0.80836359 |
| 73 | GRK5 | 0.80616095 |
| 74 | BLK | 0.78297486 |
| 75 | CSK | 0.76770537 |
| 76 | CSF1R | 0.73764404 |
| 77 | IKBKE | 0.73489989 |
| 78 | FGFR2 | 0.72965122 |
| 79 | KIT | 0.72791934 |
| 80 | PAK1 | 0.72376039 |
| 81 | PRKCZ | 0.72326093 |
| 82 | BTK | 0.70898815 |
| 83 | CDK6 | 0.70478250 |
| 84 | CDC42BPA | 0.69626048 |
| 85 | MAPK12 | 0.67308964 |
| 86 | NME2 | 0.64965937 |
| 87 | EPHB1 | 0.64807046 |
| 88 | LATS1 | 0.63026313 |
| 89 | PRKACG | 0.62809560 |
| 90 | PRKD1 | 0.61399547 |
| 91 | FER | 0.61126307 |
| 92 | MAP4K1 | 0.57732856 |
| 93 | TGFBR1 | 0.57201694 |
| 94 | CAMK2G | 0.56125057 |
| 95 | ERBB2 | 0.54634263 |
| 96 | SCYL2 | 0.53765053 |
| 97 | TAOK1 | 0.53018159 |
| 98 | EPHA2 | 0.52390664 |
| 99 | STK16 | 0.51572107 |
| 100 | PTK2B | 0.50905620 |
| 101 | ROCK1 | 0.50332925 |
| 102 | CAMK2B | 0.49663727 |
| 103 | MAP3K13 | 0.49291870 |
| 104 | MET | 0.48512329 |
| 105 | CAMK1D | 0.48462228 |
| 106 | PIK3CA | 0.47833743 |
| 107 | CDK4 | 0.45683649 |
| 108 | PAK4 | 0.45272739 |
| 109 | MAPKAPK2 | 0.44991491 |
| 110 | GSK3A | 0.44912096 |
| 111 | MAP3K2 | 0.43806340 |
| 112 | PRKCA | 0.43366891 |
| 113 | ACVR1B | 0.42855728 |
| 114 | PTK2 | 0.42457196 |
| 115 | FGFR3 | 0.41864895 |
| 116 | DYRK1B | 0.40692096 |
| 117 | PDPK1 | 0.39965167 |
| 118 | MAPK7 | 0.39282614 |
| 119 | MAP3K5 | 0.37693371 |
| 120 | DMPK | 0.37397447 |
| 121 | MAP2K1 | 0.37053693 |
| 122 | TEC | 0.36899112 |
| 123 | IGF1R | 0.35564760 |
| 124 | PRKAA1 | 0.35513067 |
| 125 | PDK3 | 0.34422093 |
| 126 | PDK4 | 0.34422093 |
| 127 | TAOK2 | 0.34347526 |
| 128 | PDK1 | 0.33571549 |
| 129 | PRKCQ | 0.33470161 |
| 130 | DAPK1 | 0.31850854 |
| 131 | SYK | 0.31014827 |
| 132 | TESK2 | 0.30995096 |
| 133 | ITK | 0.30661816 |
| 134 | EGFR | 0.29340877 |
| 135 | PRKG2 | 0.28457878 |
| 136 | PIM2 | 0.28283858 |
| 137 | MAP3K6 | 0.28008848 |
| 138 | LRRK2 | 0.27874341 |
| 139 | LYN | 0.27494622 |
| 140 | MAP3K1 | 0.27470827 |
| 141 | GRK1 | 0.27468560 |
| 142 | MAP2K2 | 0.27217630 |
| 143 | PRKCD | 0.25900126 |
| 144 | IKBKB | 0.25215446 |
| 145 | JAK3 | 0.24343947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41153354 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44522658 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.07741732 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.06113064 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80175671 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69678093 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69221401 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61010329 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57289670 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56391533 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51939549 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47256588 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39781627 |
| 14 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.25514473 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15223352 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.14353289 |
| 17 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.06063201 |
| 18 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05096262 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03293256 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95718379 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90887845 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85635494 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85390503 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83366988 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77469579 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76615382 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73223124 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72061304 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67206652 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65102266 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58656866 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57388057 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56586147 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55614905 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55186804 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50527157 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48326838 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.43342918 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42214695 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.41863268 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.41712336 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40398837 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.38948360 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37641617 |
| 45 | Mineral absorption_Homo sapiens_hsa04978 | 1.27586495 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26968877 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23176636 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21600814 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19357453 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.17218449 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11837323 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08911548 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.08681514 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05229288 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04573027 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03323354 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 1.03010378 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96249729 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94928653 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89887152 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88638200 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88634127 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86929217 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83627085 |
| 65 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.82533485 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81022564 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79963565 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78044587 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77519310 |
| 70 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75790971 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72114497 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.71569996 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71062992 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68504546 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67378393 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66413182 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60084894 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58564563 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56311974 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55877125 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51223831 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50168269 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50108078 |
| 84 | Proteasome_Homo sapiens_hsa03050 | 0.48288333 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47402316 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46894376 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46488102 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44193974 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43732513 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43604417 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41106679 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40451756 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.37407496 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35236391 |
| 95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35216574 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31268358 |
| 97 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29188426 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.28999763 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.28806940 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28195742 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23067091 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22205389 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.21461064 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19328566 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17145762 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09338088 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07873903 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07155575 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01265596 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2007766 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1916212 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1893654 |
| 113 | Pertussis_Homo sapiens_hsa05133 | -0.1882491 |
| 114 | Lysosome_Homo sapiens_hsa04142 | -0.1756880 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | -0.1753515 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1741171 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | -0.1612000 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1610476 |
| 119 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1562584 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1457588 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1236374 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1227405 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1188443 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1176692 |
| 125 | Protein export_Homo sapiens_hsa03060 | -0.1110142 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0853189 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0822790 |
| 128 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0364724 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0287285 |

